Briana Anderson - Cornell University

More documents

Recommendations

Info

48 which endorser trustworthiness is the dependent variable. In this model, the objective attractiveness variable had a significance level of .000. Table 18 Means for Dependent Variable: Endorser Trustworthiness Mean Endorser Trustworthiness Std. Error 95% Confidence Interval Endorser Lower Upper Bound Bound Unattractive 34.184 .663 32.878 35.489 Attractive 30.105 .663 28.799 31.410 ** Evaluated at covariates appeared in the model: gender = .8088, class = .5074. H1c: Based on the same set of research, attractiveness should have a positive relationship with endorser expertise. Similar to Hypotheses H1a and H1b, H1c was also not supported with an ANOVA test, and the opposite of H1c’s prediction was significantly supported by this analysis – there is a negative relationship between endorser attractiveness and perceptions of endorser expertise. Table 19 below presents the means from a univariate ANOVA test in which endorser expertise is the dependent variable. In this model, the objective attractiveness variable was significant at a level of .000.
Table 19 49 Means for Dependent Variable: Endorser Expertise Mean Endorser Expertise Std. Error 95% Confidence Interval Endorser Lower Upper Bound Bound Unattractive 34.684 .705 33.296 36.071 Attractive 28.721 .705 27.333 30.108 Evaluated at covariates appeared in the model: gender = .8088, Class= .5074. H2: Based on the Match-Up Effect, there should be an interaction between attractiveness and company type with endorser credibility. Specifically, the combination of an attractive endorser and beauty company should get a significantly higher rating of credibility than that of the combination of attractive endorser and the pharmaceutical company.
Page 1 and 2:
EFFECTS OF ENDORSER ATTRACTIVENESS
Page 3 and 4:
ABSTRACT Much research has been con
Page 5 and 6:
BIOGRAPHICAL SKETCH Born and raised
Page 7 and 8:
This thesis is dedicated to my fami
Page 9 and 10:
TABLE OF CONTENTS CHAPTER ONE - INT
Page 11 and 12: LIST OF FIGURES Figure 1 - Lafferty
Page 13 and 14: Table 22 - Means for Dependent Vari
Page 15 and 16: CHAPTER ONE INTRODUCTION Physical a
Page 17 and 18: CHAPTER TWO BACKGROUND & PURPOSE OF
Page 19 and 20: 5 they have received benefits from
Page 21 and 22: 7 A popular advertising vehicle is
Page 23 and 24: Explaining the Attractiveness-Credi
Page 25 and 26: • Attractive people are more pers
Page 27 and 28: 13 In a related study, Lafferty and
Page 29 and 30: Role of Cognitive “Involvement”
Page 31 and 32: CHAPTER THREE EXPECTATIONS Past res
Page 33 and 34: 19 such as a cosmetics or clothing
Page 35 and 36: 21 • H1b: Based on the same set o
Page 37 and 38: source credibility). Each person vi
Page 39 and 40: Table 2 Survey Versions Version 1st
Page 41 and 42: Dependent Variables: Corporate Cred
Page 43 and 44: Table 3 29 Ohanian’s (1990) Endor
Page 45 and 46: Control Variable 31 To measure pers
Page 47 and 48: CHAPTE FIVE RESULTS Pretest Results
Page 49 and 50: 35 Figure 3 - Attractive Endorser 1
Page 51 and 52: 37 Demographic and Involvement Freq
Page 53 and 54: 39 Reliability of the endorser attr
Page 55 and 56: 41 Additionally, three separate mea
Page 57 and 58: Table 13 43 Reliability for Summed
Page 59 and 60: Table 15 45 Correlation of Objectiv
Page 61: H1a: Overall, the physical attracti
Page 65 and 66: 51 illustrates that the findings ar
Page 67 and 68: cosmetics company. It is important
Page 69 and 70: 55 H3: In a high involvement condit
Page 71 and 72: Table 27 57 Means for Dependent Var
Page 73 and 74: 59 Tables 28 and 29 present the fin
Page 75 and 76: Mean Score 38 36 34 32 30 28 26 24
Page 77 and 78: Table 31 63 Means for Dependent Var
Page 79 and 80: Limitations CHAPTER SIX CONCLUSION
Page 81 and 82: confounding variables in this study
Page 83 and 84: 69 study. These hypotheses predicte
Page 85 and 86: marketing, a person’s attractiven
Page 87 and 88: APPENDIX A SURVEY INSTRUMENT Who I
Page 89 and 90: Please answer whether you agree or
Page 91 and 92: 77 Please answer whether you agree
Page 93 and 94: Pharmco Pharmaceuticals - Social Re
Page 95 and 96: REFERENCES Ashmore, R.D., Solomon,
Page 97 and 98: Ledingham, J.A. & Brunig, S.D. (200
show all

Briana Anderson - Cornell University

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?